CoChat

Insulin Resistance in PCOS Patients Enhances Oxidative Stress and Leukocyte Adhesion: Role of Myeloperoxidase

Open access
Victor, Victor M., Rovira-Llopis, Susana, Bañuls, Celia, Diaz-Morales, Noelia, Martinez de Marañon, Arantxa, Rios-Navarro, Cesar, Alvarez, Angeles, Gomez, Marcelino, Rocha, Milagros, Hernández-Mijares, Antonio · 2016 · PLOS ONE
Cited by 112

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Cardiovascular diseases and oxidative stress are related to polycystic ovary syndrome (PCOS) and insulin resistance (IR). We have evaluated the relationship between myeloperoxidase (MPO) and leukocyte activation in PCOS patients according to homeostatic model assessment of IR (HOMA-IR), and have explored a possible correlation between these factors and endocrine and inflammatory parameters. This was a prospective controlled study conducted in an academic medical center. The study population consisted of 101 PCOS subjects and 105 control subjects. We divided PCOS subjects into PCOS non-IR (HOMA-IR<2.5) and PCOS IR (HOMA-IR>2.5). Metabolic and anthropometric parameters, total and mitochondrial reactive oxygen species (ROS) production, MPO levels, interactions between human umbilical vein endothelial cells and leukocytes, adhesion molecules (E-selectin, ICAM-1 and VCAM-1) and proinflammatory cytokines (IL-6 and TNF-α) were evaluated. Oxidative stress was observed in PCOS patients, in whom there was an increase in total and mitochondrial ROS production and MPO levels. Enhanced rolling flux and adhesion, and a decrease in polymorphonuclear cell rolling velocity were also detected in PCOS subjects. Increases in IL-6 and TNF-α and adhesion molecules (E-selectin, ICAM-1 and VCAM-1) were also observed, particularly in the PCOS IR group, providing evidence that inflammation and oxidative stress are related in PCOS patients. HOMA-IR was positively correlated with hsCRP (p<0.001, r = 0.304), ROS production (p<0.01, r = 0.593), leukocyte rolling flux (p<0.05, r = 0.446), E-selectin (p<0.01, r = 0.436) and IL-6 (p<0.001, r = 0.443). The results show an increase in the rate of ROS and MPO levels in PCOS patients in general, and particularly in those with IR. Inflammation in PCOS induces leukocyte-endothelium interactions and a simultaneous increase in IL-6, TNF-α, E-selectin, ICAM-1 and VCAM-1. These conditions are aggravated by the presence of IR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0151960

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 36

  1. E Diamanti-Kandarakis, 1999, A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile, J Clin Endocrinol Metab, 84, 4006, 10.1210/jcem.84.11.6148 · DOI · Paper page
  2. A Dunaif, 1997, Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis, Endocr Rev, 18, 774
  3. DA Ehrmann, 2005, Polycystic ovary syndrome, N Engl J Med, 352, 1223, 10.1056/NEJMra041536 · DOI · Paper page
  4. K Bajuk Studen, 2013, Cardiovascular risk and subclinical cardiovascular disease in polycystic ovary syndrome, Front Horm Res, 40, 64, 10.1159/000341838 · DOI · Paper page
  5. S Mahalingaiah, 2015, Targets to treat metabolic syndrome in polycystic ovary syndrome, Expert Opin Ther Targets, 19, 1561, 10.1517/14728222.2015.1101067 · DOI · Paper page
  6. Y Zhao, 2015, Up-Regulated Expression of WNT5a Increases Inflammation and Oxidative Stressvia PI3K/AKT/NF-κB Signaling in the Granulosa Cells of PCOS Patients, J Clin Endocrinol Metab, 100, 201, 10.1210/jc.2014-2419 · DOI · Paper page
  7. HF Escobar-Morreale, 2011, Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis, Fertil Steril, 95, 1048, 10.1016/j.fertnstert.2010.11.036 · DOI · Paper page
  8. F Gonzalez, 2006, Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome, J Clin Endocrinol Metab, 91, 336, 10.1210/jc.2005-1696 · DOI · Paper page
  9. VM Victor, 2009, Mitochondrial complex I impairment in leukocytes from polycystic ovary syndrome patients with insulin resistance, J Clin Endocrinol Metab, 94, 3505, 10.1210/jc.2009-0466 · DOI · Paper page
  10. VM Victor, 2011, Induction of oxidative stress and human leukocyte/endothelial cell interactions in polycystic ovary syndrome patients with insulin resistance, J Clin Endocrinol Metab, 96, 3115, 10.1210/jc.2011-0651 · DOI · Paper page
  11. F Gonzalez, 2006, In vitro evidence that hyperglycemia stimulates tumor necrosis factor alpha release in obese women with polycystic ovary syndrome, J Endocrinol, 188, 521, 10.1677/joe.1.06579 · DOI · Paper page
  12. F Orio Jr, 2005, The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome, J Clin Endocrinol Metab, 90, 2, 10.1210/jc.2004-0628 · DOI · Paper page
  13. S Rovira-Llopis, 2013, Is myeloperoxidase a key component in the ROS-induced vascular damage related to nephropathy in type 2 diabetes?, Antioxid Redox Signal, 19, 1452, 10.1089/ars.2013.5307 · DOI · Paper page
  14. C Zhang, 2004, Leukocyte-derived myeloperoxidase amplifies high-glucose-induced endothelial dysfunction through interaction with high-glucose-stimulated, vascular non-leukocyte-derived reactive oxygen species, Diabetes, 53, 2950, 10.2337/diabetes.53.11.2950 · DOI · Paper page
  15. AL Ribeiro, 2012, Myeloperoxidases and polycystic ovary syndrome, Gynecol Endocrinol, 28, 3, 10.3109/09513590.2011.579656 · DOI
  16. SA Blair, 2013, Oxidative stress and inflammation in lean and obese subjects with polycystic ovary syndrome, J Reprod Med, 58, 107
  17. Z Kurdoglu, 2012, Serum myeloperoxidase and adenosine deaminase activities in polycystic ovary syndrome, Gynecol Endocrinol, 28, 115, 10.3109/09513590.2011.583959 · DOI
  18. B Vozarova, 2002, High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes, Diabetes, 51, 455, 10.2337/diabetes.51.2.455 · DOI · Paper page
  19. E Armeni, 2013, Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype, J Hypertens, 31, 1998, 10.1097/HJH.0b013e3283630362 · DOI · Paper page
  20. A Hernández Mijares, 2003, Prevalence of metabolic syndrome in patients with coronary heart disease, Med Clin (Barc), 121, 204
  21. S Rovira-Llopis, 2014, Is glycemic control modulating endoplasmic reticulum stress in leukocytes of type 2 diabetic patients?, Antioxid Redox Signal, 21, 1759, 10.1089/ars.2014.6030 · DOI
  22. A Hernandez-Mijares, 2013, Human leukocyte/endothelial cell interactions and mitochondrial dysfunction in type 2 diabetic patients and their association with silent myocardial ischemia, Diabetes Care, 36, 1695, 10.2337/dc12-1224 · DOI · Paper page
  23. S Palomba, 2014, Low-grade chronic inflammation in pregnant women with polycystic ovary syndrome: a prospective controlled clinical study, J Clin Endocrinol Metab, 99, 2942, 10.1210/jc.2014-1214 · DOI · Paper page
  24. Q Li, 2013, Induction of vascular insulin resistance and endothelin-1 expression and acceleration of atherosclerosis by the overexpression of protein kinase C-β isoform in the endothelium, Circ Res, 113, 418, 10.1161/CIRCRESAHA.113.301074 · DOI
  25. SM Grundy, 2007, Metabolic syndrome: a multiplex cardiovascular risk factor, J Clin Endocrinol Metab, 92, 399, 10.1210/jc.2006-0513 · DOI · Paper page
  26. D Prieto, 2014, Endothelial dysfunction, obesity and insulin resistance, Curr Vasc Pharmacol, 12, 412, 10.2174/1570161112666140423221008 · DOI · Paper page
  27. N Anatoliotakis, 2013, Myeloperoxidase: expressing inflammation and oxidative stress in cardiovascular disease, Curr Top Med Chem, 13, 115, 10.2174/1568026611313020004 · DOI · Paper page
  28. M Unubol, 2015, Relationship between glycemic control and histochemicale M, et al.; 77: 598–625.25. al. Myeloperoxidase: expressing inf diabetes, Diabetol Metab Syndr, 7, 119, 10.1186/s13098-015-0115-3 · DOI
  29. EA Podrez, 1999, Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro, J Clin Invest, 103, 1547, 10.1172/JCI5549 · DOI · Paper page
  30. JP Eiserich, 2002, Myeloperoxidase, a leukocyte-derived vascular NO oxidase, Science, 296, 2391, 10.1126/science.1106830 · DOI · Paper page
  31. JA Vita, 2004, Serum myeloperoxidase levels independently predict endothelial dysfunction in humans, Circulation, 10, 1134, 10.1161/01.CIR.0000140262.20831.8F · DOI · Paper page
  32. S Baldus, 2004, Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion, Free Radic Biol Med, 37, 902, 10.1016/j.freeradbiomed.2004.06.003 · DOI
  33. IV Gorudko, 2015, Binding of human myeloperoxidase to red blood cells: Molecular targets and biophysical consequences at the plasma membrane level, Arch Biochem Biophys, 591, 87, 10.1016/j.abb.2015.12.007 · DOI
  34. M Nasiek, 2004, Plasma concentration of soluble intercellular adhesion molecule-1 in women with polycystic ovary syndrome, Gynecol Endocrinol, 19, 208, 10.1080/09513590400014313 · DOI
  35. A Klinke, 2011, Myeloperoxidase attracts neutrophils by physical forces, Blood, 117, 1350, 10.1182/blood-2010-05-284513 · DOI · Paper page
  36. C Nussbaum, 2013, Myeloperoxidase: a leukocyte-derived protagonist of inflammation and cardiovascular disease, Antioxid Redox Signal, 18, 692, 10.1089/ars.2012.4783 · DOI · Paper page

Cited by

See all 112

Metadata

Authors
Victor, V. M., Rovira-Llopis, S., Bañuls, C., Diaz-Morales, N., Martinez de Marañon, A., Rios-Navarro, C., Alvarez, A., Gomez, M., Rocha, M., & Hernández-Mijares, A.
Venue
PLOS ONE
Published
2016-03-23
Volume
11
Issue
3
Pages
e0151960
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2308432574
Cited by
112
References
9
FWCI
12.36
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.